Editorial of the Special Issue: Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer

by Zong Sheng Guo, David L. Bartlett
Published 2017-08-01

Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity

by Zong Sheng eGuo, Zuqiang eLiu, David L Bartlett
Published 2014-04-01

Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy

by Zuqiang Liu, Roshni Ravindranathan, Pawel Kalinski, Z. Sheng Guo, David L. Bartlett
Published 2017-03-01

In Situ Therapeutic Cancer Vaccination with an Oncolytic Virus Expressing Membrane-Tethered IL-2

by Weilin Liu, Enyong Dai, Zuqiang Liu, Congrong Ma, Zong Sheng Guo, David L. Bartlett
Published 2020-06-01

Rational application of targeted therapeutics in mucinous colon/appendix cancers with positive predictive factors

by Ashokkumar Dilly, Brendon D. Honick, Yong J. Lee, David L. Bartlett, Haroon A. Choudry
Published 2020-03-01

Synergistic apoptosis following endoplasmic reticulum stress aggravation in mucinous colon cancer

by Ashok K. Dilly, Brendon D. Honick, Yong J. Lee, David L. Bartlett, Haroon A. Choudry
Published 2020-08-01

Expression of CCL19 from Oncolytic Vaccinia Enhances Immunotherapeutic Potential while Maintaining Oncolytic Activity

by Jun Li, Mark O'Malley, Padma Sampath, Pawel Kalinski, David L. Bartlett, Steve H. Thorne
Published 2012-12-01

Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2

by Zuqiang Liu, Yan Ge, Haiyan Wang, Congrong Ma, Mathilde Feist, Songguang Ju, Z. Sheng Guo, David L. Bartlett
Published 2018-11-01

Suppressive IL-17A+Foxp3+ and ex-Th17 IL-17AnegFoxp3+ Treg cells are a source of tumour-associated Treg cells

by Stephanie Downs-Canner, Sara Berkey, Greg M. Delgoffe, Robert P. Edwards, Tyler Curiel, Kunle Odunsi, David L. Bartlett, Nataša Obermajer
Published 2017-03-01

Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives

by Zong Sheng Guo, Zong Sheng Guo, Zuqiang Liu, Zuqiang Liu, Stacy Kowalsky, Stacy Kowalsky, Mathilde Feist, Mathilde Feist, Mathilde Feist, Pawel Kalinski, Pawel Kalinski, Pawel Kalinski, Binfeng Lu, Binfeng Lu, Walter J. Storkus, Walter J. Storkus, Walter J. Storkus, David L. Bartlett, David L. Bartlett
Published 2017-05-01

Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics

by Zong Sheng Guo, Binfeng Lu, Zongbi Guo, Esther Giehl, Mathilde Feist, Enyong Dai, Weilin Liu, Walter J. Storkus, Yukai He, Zuqiang Liu, David L. Bartlett
Published 2019-01-01

In Vivo Priming of Peritoneal Tumor-Reactive Lymphocytes With a Potent Oncolytic Virus for Adoptive Cell Therapy

by Esther Giehl, Esther Giehl, Hiromichi Kosaka, Hiromichi Kosaka, Zuqiang Liu, Mathilde Feist, Mathilde Feist, Udai S. Kammula, Michael T. Lotze, Congrong Ma, Zong Sheng Guo, David L. Bartlett
Published 2021-02-01

Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus

by Zong Sheng Guo, Zuqiang Liu, Magesh Sathaiah, Jiahu Wang, Roshni Ravindranathan, Eun Kim, Shaohua Huang, Thomas W. Kenniston, John C. Bell, Herbert J. Zeh, III, Lisa H. Butterfield, Andrea Gambotto, David L. Bartlett
Published 2017-12-01